Skip to main navigation Skip to search Skip to main content

Steering committee

Activity: Consultancy › Professional

Description

Steering Committee member for (Trontinemab phase 3)
Period1 Mar 2025 → 31 Oct 2025
Work forLa Roche
Degree of RecognitionInternational